What is AAV Vectors?
Exciting News!
Discover how Tofflon's ATF technology simplifies and enhances cell cultivationATF
FDA 21 CFR Part 11 and EU Annex 11
Bioreactors and Serum-Free Medium Vaccine development and manufacturing have experienced tremendous growth in recent decades.
Tofflon Team (Fred Wu, David Luo, Way Wen, Anna Yakhutina, Irina Galushko, Elmira Amineva, Max Yin) had participated in the 7th International Scientific Practical Conference
Unlocking the Potential of CHO Cells for Bioprocessing Chinese hamster ovary (CHO) cells have become the foremost platform for manufacturing therapeutic antibodies and proteins.
